en
Scientific article
Open access
English

One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond

Published inAlzheimer's Research and Therapy, vol. 9, no. 1, 43
Publication date2017
Abstract

Hyperhomocysteinemia is a risk factor for cognitive decline and dementia, including Alzheimer disease (AD). Homocysteine (Hcy) is a sulfur-containing amino acid and metabolite of the methionine pathway. The interrelated methionine, purine, and thymidylate cycles constitute the one-carbon metabolism that plays a critical role in the synthesis of DNA, neurotransmitters, phospholipids, and myelin. In this study, we tested the hypothesis that one-carbon metabolites beyond Hcy are relevant to cognitive function and cerebrospinal fluid (CSF) measures of AD pathology in older adults.

Keywords
  • Aged
  • Alzheimer Disease/cerebrospinal fluid/diagnosis/epidemiology
  • Biomarkers/blood/cerebrospinal fluid
  • Carbon/blood
  • Carbon Compounds, Inorganic/cerebrospinal fluid
  • Cognition Disorders/cerebrospinal fluid/diagnosis/epidemiology
  • Comorbidity
  • Female
  • Homocysteine/cerebrospinal fluid
  • Humans
  • Male
  • Prevalence
  • Risk Factors
  • Switzerland/epidemiology
Citation (ISO format)
DAYON, Loic et al. One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond. In: Alzheimer’s Research and Therapy, 2017, vol. 9, n° 1, p. 43. doi: 10.1186/s13195-017-0270-x
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1758-9193
443views
180downloads

Technical informations

Creation06/08/2018 9:24:00 AM
First validation06/08/2018 9:24:00 AM
Update time03/15/2023 8:21:19 AM
Status update03/15/2023 8:21:17 AM
Last indexation02/12/2024 11:33:20 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack